USPTO serial 79309367
TARGINTA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 12, 2022
- Examiner
- REID, CAILE MAUREEN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TARGINTA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Julie A. Greenberg
Julie A. Greenberg Reising Ethington P.C.755 W Big Beaver Rd, Suite 1850Troy, MI 48084United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations for use in industry and science; stem cells for research or scientific purposes; antibodies for research and industrial purposes, namely, Biochemicals in the nature of monoclonal antibodies for in vitro scientific or research use, Laboratory chemicals in the nature of an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use, Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; DNA and RNA for scientific and industrial purposes, namely, Test particles for biodetection systems, biological analogues and microscopic carrier beads with chemically attached DNA fragments for use in testing the operation of equipment used for analyzing air for the presence of harmful biological substances, Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields, Reagent kit comprising enzyme and chemicals for in vitro transcription of RNA and modified RNA, Gene-based RNA molecular network biomarker reagents for research purposes; proteins for use in science being protein in raw material form for scientific research; chemical test kits, consisting of stem cells, antibodies and proteins, for scientific and industrial purposes for laboratory or research use; reagents for scientific purposes; diagnostic reagents for scientific purposes, not for medical or veterinary purposes; analytical preparations being Chemical buffer and standard solutions used in analytical chemistry, Reagents used for analytical moisture determinations, Reagents for use in scientific apparatus for chemical or biological analysis, Laboratory chemicals in the nature of an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use, Chemical substances for analyses in laboratories, other than for medical or veterinary purposes for scientific purposes related to cancer treatment and therapies | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations for the treatment of cancer and for cancer therapies used in the treatment of cancer; stem cells for medical purposes; stem cells for medical and veterinary use; DNA and RNA for medical and veterinary purposes, namely, gene-based RNA molecular network biomarker reagents for medical diagnosis purposes, Medical therapeutic preparations in the nature of biologically active antisense DNA or RNA compounds, Biological products for medical use in recombinant DNA technology in the nature of DNA products allowing recombinant production of polypeptides and monoclonal antibodies; surgical implants grown from stem cells comprising living tissues; antibodies, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; biological preparations for the treatment of cancer for medical and veterinary purposes; diagnostic kit consisting of stem cells, monoclonal antibodies and proteins for use in disease testing for medical and veterinary purposes; Reagents for medical use, namely, reagents for medical diagnosis and analysis; diagnostic preparations for medical and veterinary use | ACTIVE | — |
| 042 | Scientific research; laboratory testing services, namely, scientific research, diagnosis, testing and analysis in the fields of medicine, chemistry, stem cells, RNA, DNA, antibodies and proteins; basic and clinical research in the field of respiratory science and medicine, in particular in relation to the development of medicines; research and development services in the field of diagnostic preparations; quality control for others | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Targinta AB
- Other trademarks owned by Targinta AB
- Other trademarks owned by Targinta AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named TARGINTA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 6, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 6, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 6, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 7, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 19, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 19, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 12, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 12, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 12, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 3, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 26, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 26, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 13, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 13, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 6, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 24, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 24, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 24, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 24, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 24, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 16, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 15, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 15, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 9, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 25, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 27, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 27, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 10, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 9, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 27, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 27, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 23, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 22, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |